Arrow Greentech Ltd
Incorporated in 1982, Arrow Greentech
Ltd is in the business of bio-degradable (green) products, high-tech products and having Patents income for such products /technology[1]
- Market Cap ₹ 1,070 Cr.
- Current Price ₹ 709
- High / Low ₹ 826 / 342
- Stock P/E 18.0
- Book Value ₹ 147
- Dividend Yield 0.55 %
- ROCE 28.5 %
- ROE 20.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 76.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.7%
- Promoter holding has increased by 0.82% over last quarter.
- Company's median sales growth is 18.6% of last 10 years
Cons
- Working capital days have increased from 155 days to 285 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 | 23 | 31 | 39 | 43 | 31 | 27 | 24 | 106 | 132 | 201 | 157 | 201 | |
| 11 | 11 | 15 | 27 | 46 | 28 | 23 | 29 | 78 | 80 | 118 | 101 | 123 | |
| Operating Profit | 9 | 12 | 16 | 12 | -3 | 4 | 3 | -5 | 28 | 52 | 83 | 56 | 78 |
| OPM % | 46% | 51% | 52% | 31% | -7% | 12% | 13% | -22% | 26% | 39% | 41% | 35% | 39% |
| 1 | 5 | 2 | 10 | 7 | 2 | 3 | 7 | 4 | 6 | 5 | 8 | 8 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 4 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 |
| Profit before tax | 9 | 16 | 17 | 18 | 1 | 2 | 2 | -3 | 27 | 52 | 83 | 58 | 81 |
| Tax % | 30% | 29% | 18% | 16% | 81% | 7% | -57% | -43% | 29% | 25% | 25% | 27% | |
| 7 | 11 | 14 | 15 | 0 | 2 | 3 | -2 | 19 | 39 | 62 | 42 | 59 | |
| EPS in Rs | 4.65 | 7.96 | 9.79 | 10.74 | 0.13 | 1.50 | 1.79 | -1.21 | 12.51 | 26.05 | 41.03 | 28.16 | 39.36 |
| Dividend Payout % | 45% | 47% | 48% | 16% | 309% | 0% | 0% | 0% | 8% | 8% | 10% | 18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 42% |
| 3 Years: | 14% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 77% |
| 3 Years: | 31% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 43% |
| 3 Years: | 30% |
| 1 Year: | 16% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 27% |
| 3 Years: | 31% |
| Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 15 | 15 | 15 | 15 |
| Reserves | 10 | 16 | 30 | 38 | 36 | 44 | 46 | 44 | 73 | 111 | 170 | 206 |
| 0 | 0 | 0 | 0 | 0 | 5 | 4 | 4 | 3 | 0 | 0 | 2 | |
| 9 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 15 | 10 | 12 | 11 | |
| Total Liabilities | 31 | 33 | 47 | 56 | 55 | 70 | 71 | 69 | 106 | 136 | 196 | 234 |
| 5 | 5 | 16 | 16 | 13 | 17 | 15 | 14 | 12 | 15 | 17 | 18 | |
| CWIP | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 3 | 2 | 0 |
| Investments | 15 | 16 | 19 | 26 | 12 | 11 | 6 | 2 | 1 | 37 | 82 | 113 |
| 9 | 11 | 11 | 14 | 28 | 42 | 50 | 52 | 92 | 81 | 95 | 103 | |
| Total Assets | 31 | 33 | 47 | 56 | 55 | 70 | 71 | 69 | 106 | 136 | 196 | 234 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 7 | 12 | 3 | -10 | 10 | -0 | 1 | 10 | 20 | 66 | 29 | |
| -11 | 3 | -12 | 1 | 14 | -23 | -0 | 0 | -18 | -16 | -58 | -27 | |
| -2 | -7 | -2 | -6 | -2 | 12 | -1 | -1 | 9 | -4 | -4 | -7 | |
| Net Cash Flow | -3 | 3 | -2 | -2 | 2 | -0 | -2 | 0 | 0 | -1 | 5 | -4 |
| Free Cash Flow | 6 | 8 | 1 | 1 | -11 | 1 | -2 | -3 | 7 | 9 | 60 | 27 |
| CFO/OP | 123% | 119% | 95% | 55% | 305% | 295% | 13% | -30% | 45% | 67% | 107% | 80% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 9 | 21 | 29 | 59 | 31 | 91 | 42 | 72 | 67 | 43 | 72 |
| Inventory Days | 72 | 155 | 225 | 200 | 77 | 92 | 136 | 215 | 103 | 155 | 85 | 125 |
| Days Payable | 171 | 182 | 238 | 101 | 43 | 74 | 71 | 107 | 59 | 19 | 24 | 23 |
| Cash Conversion Cycle | -90 | -19 | 8 | 128 | 93 | 48 | 156 | 150 | 116 | 203 | 103 | 174 |
| Working Capital Days | -102 | -35 | 8 | 60 | 83 | 16 | 74 | 63 | 76 | 115 | 65 | 285 |
| ROCE % | 46% | 64% | 48% | 39% | 2% | 6% | 4% | -4% | 36% | 49% | 53% | 29% |
Insights
In beta| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Granted Patents (In-force) count |
|
|||||||||
| Avery Pharma FSSAI Approved Products count |
||||||||||
| Avery Pharma RX (Prescription) Approved Products count |
||||||||||
| Patent Applications in Process (Total) count |
||||||||||
| Registered Trademarks count |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Presentation On Business Performance Of The Company
- Arrow Greentech released Q1 FY27 investor presentation; revenue rose 110% QoQ to Rs. 878 million, PAT to Rs. 274 million.
- Newspaper Publication
-
Press Release On Financial Result
- Arrow Greentech reported Q1 FY27 revenue of Rs. 878 million and PAT of Rs. 274 million.
-
Board Meeting Outcome for Outcome Of The Board Meeting
- Board approved Q1 FY2026-27 results, AGM on 18 Sept 2026, auditor appointments, and Green Segment CEO.
-
Grant Of Patent
- Arrow Greentech granted India patent No. 598211 for Dual Color Shift Security Film on 6 August 2026.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Oct 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Jun 2023TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Aug 2016TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Business Overview:[1][2]
AGL is India’s largest manufacturer of water-soluble films, specializing in the development, production, and marketing of a diverse range of PVA/PVOH-based films. Its portfolio includes innovative applications such as mouth dissolving strips for pharmaceutical and nutraceutical use. In addition to green packaging solutions, AGL also offers advanced security products and intellectual property services, positioning itself as a multi-vertical technology-driven company.